Pretherapy platelet-to-lymphocyte ratio as a prognostic parameter for locally advanced hypopharyngeal cancer patients treated with radiotherapy combined with chemotherapy.

Wan, Meng; Zhao, Dan; Liu, Weixin; Huang, Zhou; Xu, Xiaolong; Zheng, Baomin; Xiao, Shaowen; Sun, Yan; Wang, Weihu

Wan, Meng; Zhao, Dan; Liu, Weixin; Huang, Zhou; Xu, Xiaolong; Zheng, Baomin; Xiao, Shaowen; Sun, Yan; Wang, Weihu.

Afiliação

Wan M; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, No.52 Fucheng Road, Haidian District, Beijing, 100142, People's Republic of China.
Zhao D; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, No.52 Fucheng Road, Haidian District, Beijing, 100142, People's Republic of China.
Liu W; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, No.52 Fucheng Road, Haidian District, Beijing, 100142, People's Republic of China.
Huang Z; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, No.52 Fucheng Road, Haidian District, Beijing, 100142, People's Republic of China.
Xu X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, No.52 Fucheng Road, Haidian District, Beijing, 100142, People's Republic of China.
Zheng B; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, No.52 Fucheng Road, Haidian District, Beijing, 100142, People's Republic of China.
Xiao S; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, No.52 Fucheng Road, Haidian District, Beijing, 100142, People's Republic of China.
Sun Y; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, No.52 Fucheng Road, Haidian District, Beijing, 100142, People's Republic of China. lisaysun@139.com.
Wang W; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiation Oncology, Peking University Cancer Hospital and Institute, No.52 Fucheng Road, Haidian District, Beijing, 100142, People's Republic of China. wangweihu88@163.com.

Eur Arch Otorhinolaryngol ; 279(12): 5859-5868, 2022 Dec.

Article em En | MEDLINE | ID: mdl-35849189

Assuntos

Neoplasias Hipofaríngeas; Humanos; Prognóstico; Neoplasias Hipofaríngeas/terapia; Neoplasias Hipofaríngeas/patologia; Linfócitos/patologia; Plaquetas/patologia; Modelos de Riscos Proporcionais; Estudos Retrospectivos; Neutrófilos

Palavras-chave

Hypopharyngeal carcinoma; Local failure; Platelet-to-lymphocyte ratio; Radiotherapy; Survival

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Hipofaríngeas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google